Earnings · China A-shares
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A (002932) earnings
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit -351.37% year on year, -17.92% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +1.55% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -351.37%
- Excl. one-offs YoY
- -17.92%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.48% | — |
| 3 days | +1.55% | — |
| 7 days | +2.32% | — |
| 14 days | -1.69% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 8 reports (average -0.31%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥33.97M | -351.37% | -17.92% | +23.91% | -0.16 | -0.85% | +1.55% | — | — |
| 2026 interim report | 2026-08-28 | -¥21.87M | -274.98% | -36.95% | +1.54% | -0.10 | -0.40% | +0.59% | -4.84% | +4.85% |
| 2026 Q1 report | 2026-04-29 | -¥377.40K | +89.70% | +23.10% | +1.01% | 0.00 | -0.01% | -2.72% | -14.59% | -15.54% |
| 2025 annual report | 2026-04-21 | -¥16.46M | -122.09% | +16.71% | -24.28% | -0.07 | -0.29% | -3.79% | -9.31% | -12.75% |
| 2025 Q3 report | 2025-10-31 | ¥13.52M | -83.30% | -62.07% | +0.53% | 0.06 | 0.24% | -1.15% | -7.24% | -2.55% |
| 2025 interim report | 2025-08-28 | ¥12.50M | -80.82% | -23.59% | -9.71% | 0.06 | 0.21% | -4.42% | -5.92% | -11.42% |
| 2025 Q1 report | 2025-04-30 | -¥3.66M | -111.43% | +7.31% | +14.76% | -0.02 | -0.06% | +0.32% | +5.84% | +2.66% |
| 2024 annual report | 2025-04-25 | ¥74.52M | -0.54% | -12.74% | -53.30% | 0.33 | 1.25% | +7.18% | +20.56% | +17.32% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.